Back
Status filter :


RESET SEARCH AND FILTERS
Nervous system
Nervous system / Epilepsy and other seizure disorders
  acetazolamide On Formulary
  Modified-release capsule
Diamox SR (Advanz Pharma) On Formulary
  Powder for solution for injection
Diamox (Advanz Pharma) Hospital Only
  brivaracetam On Formulary
  Oral solution
Briviact (UCB Pharma Ltd) On Formulary
  Solution for injection
Briviact (UCB Pharma Ltd) On Formulary
  cannabidiol On Formulary NICE TA614
NICE TA615
NICE TA873
Schedule 2 Controlled Drug

Schedule 2 Controlled Drug

  carbamazepine On Formulary
Antiepileptic Adjustment Chart

see attached

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Modified-release tablet
Tegretol Retard (Novartis Pharmaceuticals UK Ltd) On Formulary
  Oral suspension
Carbamazepine (Non-proprietary) On Formulary
Tegretol (Novartis Pharmaceuticals UK Ltd) On Formulary
  Suppository
Carbamazepine (Non-proprietary) On Formulary
  clobazam On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

Difficult to Obtain Letter

  Oral suspension
Clobazam (Non-proprietary) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

Difficult to Obtain Letter

see attached

Perizam (Rosemont Pharmaceuticals Ltd) On Formulary
Zacco (Thame Laboratories Ltd) On Formulary
  clonazepam On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

Difficult to Obtain Letter

  Oral solution
Clonazepam (Non-proprietary) On Formulary
  ethosuximide On Formulary
Antiepileptic Adjustment Chart

Antiepileptic Adjustment Chart

  Oral solution
Ethosuximide (Non-proprietary) On Formulary
Antiepileptic Adjustment Chart

Antiepileptic adjustment chart

  fosphenytoin sodium On Formulary
  gabapentin On Formulary
Barts Health Guidelines for Treating Acute Pain in Paediatric Patients

see attached

Antiepileptic Adjustment Chart

Antiepileptic Adjustment Chart

  Oral solution
Gabapentin (Non-proprietary) On Formulary
Barts Health Guidelines for Treating Acute Pain in Paediatric Patients

see attached

Antiepileptic Adjustment Chart

Antiepileptic Adjustment Chart

  lacosamide On Formulary
Antiepileptic Adjustment Chart

Antiepileptic Adjustment Chart

  lamotrigine On Formulary
Antiepileptic Adjustment Chart

Antiepileptic Adjustment Chart

  levetiracetam On Formulary
  Oral solution
Levetiracetam (Non-proprietary) On Formulary
Keppra (UCB Pharma Ltd) On Formulary
  Solution for infusion
Levetiracetam (Non-proprietary) On Formulary
Keppra (UCB Pharma Ltd) On Formulary
  oxcarbazepine On Formulary
Antiepileptic Adjustment Chart

  perampanel On Formulary
  phenobarbital On Formulary
Agreed standard strength - paediatrics

 

Phenobarbital

50mg/5ml alcohol free liquid should be used for all children

15mg/5ml should not be used in paediatrics (BP product contains exessive alcohol)

Difficult to Obtain Letter

see attached

NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH

see attached

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached 

  phenytoin On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

NEONATAL FORMULARY VERSION 10

see attached

  Chewable tablet
Epanutin (Viatris UK Healthcare Ltd) On Formulary
  Oral suspension
Epanutin (Viatris UK Healthcare Ltd) On Formulary
  Solution for injection
Phenytoin (Non-proprietary) Hospital Only
Parenteral preparations

Hospital use only

Epanutin (Viatris UK Healthcare Ltd) On Formulary
  rufinamide On Formulary
  Oral suspension
Inovelon (Eisai Ltd) On Formulary
  sodium valproate On Formulary
Management of Infantile Spasms and West Syndrome

Management of Infantile Spasms and West Syndrome June 2016

Antiepileptic Adjustment Chart

Antiepileptic Adjustment Chart

  Modified-release tablet
Epilim Chrono (Sanofi) On Formulary
Epival CR (G.L. Pharma UK Ltd) On Formulary
  Gastro-resistant tablet
Sodium valproate (Non-proprietary) On Formulary
Epilim (Sanofi) On Formulary
  Modified-release capsule
Episenta (Desitin Pharma Ltd) On Formulary
  Modified-release granules
Epilim Chronosphere MR (Sanofi) On Formulary
Episenta (Desitin Pharma Ltd) On Formulary
  Oral solution
Sodium valproate (Non-proprietary) On Formulary
Epilim (Sanofi) On Formulary
  Solution for injection
Sodium valproate (Non-proprietary) On Formulary
  Powder and solvent for solution for injection
Sodium valproate (Non-proprietary) On Formulary
  stiripentol On Formulary
Stiripentol shared care guideline_March 2016

Stiripentol shared care guideline March 2016

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached 

  tiagabine On Formulary
  topiramate On Formulary
Management of Infantile Spasms and West Syndrome

see attached

Antiepileptic Adjustment Chart

see attached

  vigabatrin On Formulary
Management of Infantile Spasms and West Syndrome

Management of Infantile Spasms and West Syndrome June 2016

Antiepileptic Adjustment Chart

Antiepileptic Adjustment Chart

  zonisamide On Formulary
Management of Infantile Spasms and West Syndrome

Management of Infantile Spasms and West Syndrome June 2016

Nervous system / Status epilepticus
  diazepam On Formulary
Diazepam

Injection formulation is Hospital Only

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH

see attached

  fosphenytoin sodium On Formulary
  lorazepam Hospital Only
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

LORAZEPAM

Injection Formulation is Hospital Use Only

  midazolam On Formulary
NEONATAL FORMULARY VERSION 10

See attached

Paediatric Premedication Guideline

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

Buccal midazolam

For buccal midazolam doses less than 2.5mg Buccolam pre filled syringes cannot be used; use midazolam oromucosal solution 10mg/ml 4 dose pack (ie 5ml Bottle with 4 syringes pack; Epistatus brand; Unlicensed medicine)

For all other doses Bucccolam (licensed) should be used 

oral midazolam solution

Oral Midazolam liquid is switching to 5mg/mL (Miprosed)

This is for the ORAL SOLUTION only for use in oral sedation (not for buccal use)

This product (a 7.5mL bottle) is for single use only and hence needs to be discarded after each use.

  Oral solution
Ozalin (Primex Pharmaceuticals Oy) Off Formulary
  Oromucosal solution
Buccolam (Neuraxpharm UK Ltd) On Formulary
Midazolam Shared Care Guideline

Midazolam Shared Care Guideline

Paediatric Premedication Guideline

Paediatric Premedication Guideline

  paraldehyde On Formulary
NEONATAL FORMULARY VERSION 10

see atatcehd

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  phenytoin On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

NEONATAL FORMULARY VERSION 10

see attached

  Chewable tablet
Epanutin (Viatris UK Healthcare Ltd) On Formulary
  Oral suspension
Epanutin (Viatris UK Healthcare Ltd) On Formulary
  Solution for injection
Phenytoin (Non-proprietary) Hospital Only
Parenteral preparations

Hospital use only

Epanutin (Viatris UK Healthcare Ltd) On Formulary
  thiopental sodium On Formulary
NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH

THIOPENTAL SODIUM

Hospital Use Only

  Powder for solution for injection
Thiopental sodium (Non-proprietary) On Formulary
Thiopental

Hospital Use Only

Nervous system / Local anaesthesia
  adrenaline with articaine hydrochloride Hospital Only
  Solution for injection
Septanest (Septodont Ltd) Hospital Only
  bupivacaine hydrochloride Hospital Only
BUPIVACAINE HYDROCHLORIDE

Hospital Use Only

  Solution for injection
Bupivacaine hydrochloride (Non-proprietary) On Formulary
BUPIVACAINE HYDROCHLORIDE

Hospital Use Only

  Infusion
Bupivacaine hydrochloride (Non-proprietary) On Formulary
BUPIVACAINE HYDROCHLORIDE

Hospital Use Only

  bupivacaine with adrenaline Hospital Only
Bupivacaine and Adrenaline

Hospital Use Only

  Solution for injection
Bupivacaine with adrenaline (Non-proprietary) On Formulary
Bupivacaine and Adrenaline

Hospital Use Only

  levobupivacaine On Formulary
LEVOBUPIVACAINE

Hospital Use Only

  Solution for injection
Chirocaine (AbbVie Ltd) On Formulary
LEVOBUPIVACAINE

Hospital Use Only

  lidocaine hydrochloride On Formulary
NEONATAL FORMULARY VERSION 8 2015 BARTS HEALTH

The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

  Solution for injection
Lidocaine hydrochloride (Non-proprietary) On Formulary
  Ointment
Lidocaine hydrochloride (Non-proprietary) On Formulary
Epistaxis in children

see attached

The Association of Paediatric Palliative Medicine Formulary - 2015

  Spray
Xylocaine (Aspen Pharma Trading Ltd) On Formulary
Epistaxis in children

see attached

The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

  lidocaine with adrenaline On Formulary
Note:

Hospital only

  Solution for injection
Xylocaine with Adrenaline (Aspen Pharma Trading Ltd, Dentsply Ltd) On Formulary
Note:

Hospital only

  lidocaine with cetrimide Off Formulary
  lidocaine with phenylephrine On Formulary
Lidocaine with phenylephrine

Hospital Use Only

  Spray
Lidocaine with phenylephrine (Non-proprietary) On Formulary
  lidocaine with prilocaine On Formulary
  mepivacaine hydrochloride On Formulary
MEPIVACAINE HYDROCHLORIDE

Hospital Use Only

  Solution for injection
Scandonest plain (Septodont Ltd) On Formulary
Scandonest® 3% Plain

Hospital Use Only

  mepivacaine with adrenaline Off Formulary
  prilocaine hydrochloride Off Formulary
PRILOCAINE HYDROCHLORIDE

Hospital Use Only

  prilocaine with felypressin Off Formulary
  ropivacaine hydrochloride Hospital Only
Ropivacaine

Hospital Use Only

  Solution for injection
Ropivacaine hydrochloride (Non-proprietary) Hospital Only
Ropivacaine

Hospital Use Only

  Infusion
Ropivacaine hydrochloride (Non-proprietary) Hospital Only
Ropivacaine

Hospital Use Only

  tetracaine On Formulary
Topical anaesthetic

Over 1 month of age:

1st line - lidocaine 4% cream - LMX4

2nd line - tetracaine 4% - Ametop 

 

  Eye drops
Tetracaine (Non-proprietary) On Formulary
Nervous system / Alcohol dependence
  carbamazepine Off Formulary
  Modified-release tablet
Tegretol Retard (Novartis Pharmaceuticals UK Ltd) Off Formulary
  Oral suspension
Carbamazepine (Non-proprietary) Off Formulary
Tegretol (Novartis Pharmaceuticals UK Ltd) Off Formulary
  Suppository
Carbamazepine (Non-proprietary) Off Formulary
  diazepam Off Formulary
Diazepam

Injection formulation is Hospital Only

Nervous system / Nicotine dependence
  nicotine On Formulary
  Sublingual tablet
Nicotine (Non-proprietary) On Formulary
Nicorette Microtab (McNeil Products Ltd) On Formulary
  Medicated chewing-gum
Nicotine (Non-proprietary) On Formulary
Nicorette (McNeil Products Ltd) On Formulary
  Transdermal patch
Nicotine (Non-proprietary) On Formulary
Nicorette invisi (McNeil Products Ltd) On Formulary
  Spray
Nicotine (Non-proprietary) On Formulary
Nicorette (McNeil Products Ltd) On Formulary
Nicorette QuickMist (McNeil Products Ltd) On Formulary
Nervous system / Opioid dependence
  buprenorphine Off Formulary
PCA NCA Policy Link

see attached

  methadone hydrochloride On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Oral solution
Methadone hydrochloride (Non-proprietary) On Formulary
Metharose (Rosemont Pharmaceuticals Ltd) On Formulary
Physeptone (Martindale Pharmaceuticals Ltd) On Formulary
Nervous system / Psychoses and schizophrenia
  amisulpride On Formulary
  aripiprazole On Formulary NICE TA213
NICE TA292
  Orodispersible tablet
Aripiprazole (Non-proprietary) On Formulary
Abilify (Otsuka Pharmaceuticals (U.K.) Ltd) On Formulary
  Oral solution
Aripiprazole (Non-proprietary) On Formulary
Abilify (Otsuka Pharmaceuticals (U.K.) Ltd) On Formulary
  chlorpromazine hydrochloride On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH

see attached

  Oral solution
Chlorpromazine hydrochloride (Non-proprietary) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

  clozapine On Formulary
CLOZAPINE

Hospital use only

  haloperidol On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Oral solution
Haloperidol (Non-proprietary) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  olanzapine On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached 

  Orodispersible tablet
Olanzapine (Non-proprietary) On Formulary
  pericyazine Off Formulary
  risperidone On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Orodispersible tablet
Risperidone (Non-proprietary) On Formulary
  Oral solution
Risperidone (Non-proprietary) On Formulary
  sulpiride On Formulary
  trifluoperazine On Formulary
  Oral solution
Trifluoperazine (Non-proprietary) On Formulary
Nervous system / Bipolar disorder and mania
  aripiprazole On Formulary NICE TA213
NICE TA292
  Orodispersible tablet
Aripiprazole (Non-proprietary) On Formulary
Abilify (Otsuka Pharmaceuticals (U.K.) Ltd) On Formulary
  Oral solution
Aripiprazole (Non-proprietary) On Formulary
Abilify (Otsuka Pharmaceuticals (U.K.) Ltd) On Formulary
  carbamazepine On Formulary
Antiepileptic Adjustment Chart

see attached

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Modified-release tablet
Tegretol Retard (Novartis Pharmaceuticals UK Ltd) On Formulary
  Oral suspension
Carbamazepine (Non-proprietary) On Formulary
Tegretol (Novartis Pharmaceuticals UK Ltd) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

  Suppository
Carbamazepine (Non-proprietary) On Formulary
  chlorpromazine hydrochloride On Formulary
  Oral solution
Chlorpromazine hydrochloride (Non-proprietary) On Formulary
  haloperidol On Formulary
  Oral solution
Haloperidol (Non-proprietary) On Formulary
  lamotrigine Off Formulary
  lithium carbonate On Formulary
  Modified-release tablet
Camcolit (Essential Pharma Ltd) On Formulary
  lithium citrate On Formulary
  Oral solution
Priadel (Essential Pharma Ltd) On Formulary
  olanzapine On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached 

  Orodispersible tablet
Olanzapine (Non-proprietary) On Formulary
  sodium valproate On Formulary
Management of Infantile Spasms and West Syndrome

Management of Infantile Spasms and West Syndrome June 2016

Antiepileptic Adjustment Chart

Antiepileptic Adjustment Chart

  Modified-release tablet
Epilim Chrono (Sanofi) On Formulary
Epival CR (G.L. Pharma UK Ltd) On Formulary
  Gastro-resistant tablet
Sodium valproate (Non-proprietary) On Formulary
Epilim (Sanofi) On Formulary
  Modified-release capsule
Episenta (Desitin Pharma Ltd) On Formulary
  Modified-release granules
Epilim Chronosphere MR (Sanofi) On Formulary
Episenta (Desitin Pharma Ltd) On Formulary
  Oral solution
Sodium valproate (Non-proprietary) On Formulary
Epilim (Sanofi) On Formulary
  Solution for injection
Sodium valproate (Non-proprietary) On Formulary
  Powder and solvent for solution for injection
Sodium valproate (Non-proprietary) On Formulary
  valproic acid On Formulary
Nervous system / Anxiety
  diazepam Off Formulary
Diazepam

Injection formulation is Hospital Only

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  lorazepam Hospital Only
  pericyazine Off Formulary
  trifluoperazine On Formulary
  Oral solution
Trifluoperazine (Non-proprietary) On Formulary
Nervous system / Depression
  amitriptyline hydrochloride Off Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

Barts Health Guidelines for Treating Acute Pain in Paediatric Patients

See attached

  Oral solution
Amitriptyline hydrochloride (Non-proprietary) On Formulary
  citalopram On Formulary
  Oral drops
Citalopram (Non-proprietary) On Formulary
  doxepin On Formulary
  fluoxetine On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Oral solution
Fluoxetine (Non-proprietary) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

  fluvoxamine maleate On Formulary
  imipramine hydrochloride On Formulary
  Oral solution
Imipramine hydrochloride (Non-proprietary) On Formulary
  lithium carbonate On Formulary
  Modified-release tablet
Camcolit (Essential Pharma Ltd) On Formulary
  lithium citrate On Formulary
  Oral solution
Priadel (Essential Pharma Ltd) On Formulary
  nortriptyline On Formulary
  sertraline On Formulary
Nervous system / Attention deficit hyperactivity disorder
  atomoxetine On Formulary
NICE TA: Attention deficit hyperactivity disorder: diagnosis and management

Methylphenidate, atomoxetine and dexamfetamine are recommended, within their licensed indications, as options for the management of ADHD in children and adolescents.

  dexamfetamine sulfate On Formulary
  Modified-release capsule
Dexamfetamine sulfate (Non-proprietary) On Formulary
Dexedrine Spansules (Imported (United States)) On Formulary
  Oral solution
Dexamfetamine sulfate (Non-proprietary) On Formulary
  methylphenidate hydrochloride On Formulary
  Modified-release tablet
Concerta XL (Janssen-Cilag Ltd) On Formulary
  Modified-release capsule
Equasym XL (Takeda UK Ltd) On Formulary
Medikinet XL (Medice UK Ltd) On Formulary
Nervous system / General anaesthesia
  desflurane Hospital Only
DESFLURANE

Hospital Use Only

  etomidate Hospital Only
  Solution for injection
Hypnomidate (Piramal Critical Care Ltd) On Formulary
Hypnomidate®

Hospital Use Only

  Emulsion for injection
Etomidate (Non-proprietary) Hospital Only
Etomidate-Lipuro®

Hospital Use Only

  isoflurane On Formulary
ISOFLURANE

Hospital Use Only

  nitrous oxide On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

NITROUS OXIDE

Hospital Use Only

  propofol On Formulary
PROPOFOL

Hospital Use Only

  Emulsion for injection
Propofol (Non-proprietary) On Formulary
Propofol

Hospital Use Only

  sevoflurane On Formulary
SEVOFLURANE

Hospital Use Only

  thiopental sodium On Formulary
NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH

THIOPENTAL SODIUM

Hospital Use Only

  Powder for solution for injection
Thiopental sodium (Non-proprietary) On Formulary
Thiopental

Hospital Use Only

Nervous system / CNS and respiratory depression
  naloxone hydrochloride On Formulary
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

see attached

NALOXONE HYDROCHLORIDE

Hospital Use Only

Barts Health Guidelines for Treating Acute Pain in Paediatric Patients

see attached

Bart's Health Clinical Practice Policy for Intravenous PCA/NCA for Paediatric Patients in Acute Pain

see attached

The Association of Paediatric Palliative Medicine Formulary - 2017

see attcahed 

  Solution for injection
Naloxone hydrochloride (Non-proprietary) On Formulary
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

see attached

Naloxone

Hospital Use Only

Barts Health Guidelines for Treating Acute Pain in Paediatric Patients

see attached

Nervous system / Reversal of benzodiazepines
  flumazenil On Formulary
FLUMAZENIL

Hospital Use Only

  Solution for injection
Flumazenil (Non-proprietary) On Formulary
Flumazenil

Hospital Use Only

Nervous system / Malignant hyperthermia
  dantrolene sodium On Formulary
Dantrium Intravenous:

Hospital Use Only

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Powder for solution for injection
Dantrium (Forum Health Products Ltd) Hospital Only
The Association of Paediatric Palliative Medicine Formulary - 2015

Dantrium Intravenous®

Hospital Use Only

Nervous system / Anaesthesia adjuvants
  atropine sulfate On Formulary
NEONATAL FORMULARY VERSION 8 2015 BARTS HEALTH

see attached

  glycopyrronium bromide Hospital Only
Difficult to Obtain Letter

see attached

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH

NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH

GLYCOPYRRONIUM BROMIDE

Injection Formulation is Hospital Use Only

Oral liquid Glycopyrronium bromide 400microg/mL (Sialanar) for use in sialorrhea. Beware of how concentration is expressed. The bromide salt content (400microg) should be used to calculate dosing.

  Solution for injection
Glycopyrronium bromide (Non-proprietary) On Formulary
Glycopyrronium bromide

Injection Formulation is Hospital Use Only

NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

see attached

The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

Nervous system / Peri-operative sedation
  alimemazine tartrate On Formulary
  Oral solution
Alimemazine tartrate (Non-proprietary) On Formulary
  diazepam On Formulary
Diazepam

Injection formulation is Hospital Only

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH

see attached

  ketamine On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

Barts Health Guidelines for Treating Acute Pain in Paediatric Patients

Oxycodone PCA is also approved for acute pain use at RLH.
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

Paediatric Premedication Guideline

KETAMINE

Hospital Use Only

  Solution for injection
Ketalar (Pfizer Ltd) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

Barts Health Guidelines for Treating Acute Pain in Paediatric Patients

Paediatric Premedication Guideline

Ketalar®

Hospital Use Only

  lorazepam Hospital Only
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

LORAZEPAM

Injection Formulation is Hospital Use Only

  midazolam On Formulary
NEONATAL FORMULARY VERSION 10

See attached

Paediatric Premedication Guideline

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

Buccal midazolam

For buccal midazolam doses less than 2.5mg Buccolam pre filled syringes cannot be used; use midazolam oromucosal solution 10mg/ml 4 dose pack (ie 5ml Bottle with 4 syringes pack; Epistatus brand; Unlicensed medicine)

For all other doses Bucccolam (licensed) should be used 

oral midazolam solution

Oral Midazolam liquid is switching to 5mg/mL (Miprosed)

This is for the ORAL SOLUTION only for use in oral sedation (not for buccal use)

This product (a 7.5mL bottle) is for single use only and hence needs to be discarded after each use.

  Oral solution
Midazolam (Non-proprietary) On Formulary
Midazolam Shared Care Guideline

see attached

Miprosed (Syri Ltd) Hospital Only
Ozalin (Primex Pharmaceuticals Oy) Off Formulary
  Solution for injection
Midazolam (Non-proprietary) On Formulary
Midazolam

Injection Formulation is Hospital Use Only

  propofol On Formulary
PROPOFOL

Hospital Use Only

  Emulsion for injection
Propofol (Non-proprietary) On Formulary
Propofol

Hospital Use Only

  remifentanil On Formulary
REMIFENTANIL

Hospital Use Only

  Powder for solution for injection
Remifentanil (Non-proprietary) On Formulary
REMIFENTANIL

Hospital Use Only

  temazepam On Formulary
Paediatric Premedication Guideline

see attached

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Oral solution
Temazepam (Non-proprietary) On Formulary
Paediatric Premedication Guideline

see attached

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

Nervous system / Neuromuscular blockade reversal
  neostigmine On Formulary
NEOSTIGMINE

Injection Formulation is Hospital Only

NEONATAL FORMULARY BARTS HEALTH

Neonatal Formulary  Barts Health

NEOSTIGMINE METILSULFATE

Hospital Use Only

  Solution for injection
Neostigmine (Non-proprietary) Hospital Only
Injection

Hospital Only Drug

NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

Neonatal Formulary Version 9 2016 Barts Health

NEOSTIGMINE METILSULFATE

Hospital Use Only

  neostigmine with glycopyrronium bromide On Formulary
The Association of Paediatric Palliative Medicine Formulary -2017

The Association of Paediatric Palliative Medicine Formulary -2017

NEOSTIGMINE WITH GLYCOPYRRONIUM

Hospital Use Only

Glycopyrronium-Neostigmine

Hospital Use Only

  Solution for injection
Neostigmine with glycopyrronium bromide (Non-proprietary) On Formulary
NEOSTIGMINE WITH GLYCOPYRRONIUM

Hospital Use Only

Glycopyrronium-Neostigmine

Hospital Use Only

  sugammadex On Formulary
SUGAMMADEX

Hospital Use Only

  Solution for injection
Bridion (Merck Sharp & Dohme (UK) Ltd) On Formulary
Bridion®

Hospital Use Only

Nervous system / Neuromuscular blockade
  atracurium besilate Hospital Only
ATRACURIUM BESILATE

Hospital Use Only

National supply shortage of neuromuscular blocking agents (NMBAs).

The trust has received notification from the Department of Health & Social Care regarding a national supply shortage of neuromuscular blocking agents (NMBAs). There is no timeline as to when the shortage will be resolved, it is however, anticipated to continue for some time. Please see the memo attached for further information for this drug shortage.

NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH

see attached

Atracurium IV monograph for NICU June 2022

Atracurium IV monograph for NICU June 2022

  Solution for injection
Atracurium besilate (Non-proprietary) Hospital Only
Atracurium

Hospital Use Only

  cisatracurium Off Formulary
  Solution for injection
Cisatracurium (Non-proprietary) Off Formulary
  mivacurium On Formulary
MIVACURIUM

Hospital Use Only

  pancuronium bromide On Formulary
PANCURONIUM BROMIDE

Hospital Use Only

  rocuronium bromide On Formulary
ROCURONIUM BROMIDE

Hospital Use Only

National supply shortage of neuromuscular blocking agents (NMBAs).

The trust has received notification from the Department of Health & Social Care regarding a national supply shortage of neuromuscular blocking agents (NMBAs). There is no timeline as to when the shortage will be resolved, it is however, anticipated to continue for some time. Please see the memo attached for further information for this drug shortage.

  Solution for injection
Rocuronium bromide (Non-proprietary) On Formulary
Rocuronium

Hospital Use Only

Esmeron (Merck Sharp & Dohme (UK) Ltd) On Formulary
Esmeron®

Hospital Use Only

  suxamethonium chloride On Formulary
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

SUXAMETHONIUM CHLORIDE

Hospital Use Only

  Solution for injection
Suxamethonium chloride (Non-proprietary) On Formulary
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

Suxamethonium Chloride

Hospital Use Only

  vecuronium bromide On Formulary
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

VECURONIUM BROMIDE

Hospital Use Only

Nervous system / Peri-operative analgesia
  alfentanil On Formulary
ALFENTANIL

Hospital Use Only

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Solution for injection
Alfentanil (Non-proprietary) Off Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

Alfentanil

Hospital Use Only

  buprenorphine Off Formulary
  Sublingual tablet
Buprenorphine (Non-proprietary) On Formulary
  diclofenac potassium Off Formulary
  fentanyl On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

Guidelines for treating acute pain in paediatric in-patients February 2018

Oxycodone PCA is also approved for acute pain use at RLH.
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

PCA NCA Policy Link

FENTANYL

Hospital Use Only

NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

See attached

Acute pain relief in sickle cell pain crisis (April 2021)

The committee have approved sublingual Fentanyl for acute pain relief in sickle cell pain crisis in paediatric patients of age 14 years and above.

  Solution for injection
Fentanyl (Non-proprietary) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

see attached

Fentanyl

Hospital Use Only

  Solution for infusion
Fentanyl (Non-proprietary) On Formulary
  flurbiprofen Off Formulary
  ibuprofen On Formulary
  ketorolac trometamol On Formulary
KETOROLAC TROMETAMOL

Injection Formulation is Hospital Use Only

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Solution for injection
Ketorolac trometamol (Non-proprietary) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

Ketorolac

Injection Formulation is Hospital Use Only

  oxycodone hydrochloride Hospital Only
  pethidine hydrochloride On Formulary
PCA NCA Policy Link

PETHIDINE HYDROCHLORIDE

Hospital use only

  Solution for injection
Pethidine hydrochloride (Non-proprietary) On Formulary
PCA NCA Policy Link

see attached

Pethidine

Hospital use only

  remifentanil On Formulary
REMIFENTANIL

Hospital Use Only

  Powder for solution for injection
Remifentanil (Non-proprietary) On Formulary
Nervous system / Pain
  alfentanil On Formulary
ALFENTANIL

Hospital Use Only

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Solution for injection
Alfentanil (Non-proprietary) Off Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

Alfentanil

Hospital Use Only

  aspirin Off Formulary
  bupivacaine hydrochloride Hospital Only
BUPIVACAINE HYDROCHLORIDE

Hospital Use Only

  Solution for injection
Bupivacaine hydrochloride (Non-proprietary) On Formulary
BUPIVACAINE HYDROCHLORIDE

Hospital Use Only

  Infusion
Bupivacaine hydrochloride (Non-proprietary) On Formulary
BUPIVACAINE HYDROCHLORIDE

Hospital Use Only

  bupivacaine with adrenaline Hospital Only
  buprenorphine Off Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Sublingual tablet
Buprenorphine (Non-proprietary) On Formulary
  co-codamol On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

Guidelines for treating acute pain in paediatric in-patients June 2015

Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome).
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

  codeine phosphate On Formulary
Guidelines for treating acute pain in paediatric in-patients February 2018

Oxycodone PCA is also approved for acute pain use at RLH.
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

Guidance on restricting codeine use in children

https://www.gov.uk/drug-safety-update/codeine-for-cough-and-cold-restricted-use-in-children

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

Paediatric Acute Sickle Cell Pain Pathway

See attached

Paediatric Acute Pain Pathway

See attached

  diamorphine hydrochloride On Formulary
Prescribing in Palliative Care


http://www.pallcare.info/ - seek advice from Macmillan Team or Palliative Care teams before using information from this website:


Palliative Care Team Contacts:

St Bartholomew's, Royal London, Mile End and London Chest

Phone: 020 3465 5600 (internal: 55600)Fax: 020 3465 5389 (internal: 55389)

Newham Phone: 020 7363 8105 Fax: 020 7363 9432

Whipps Cross – Margaret Centre Phone: 020 8535 6604 Fax: 020 8535 6952

The Association of Paediatric Palliative Medicine Formulary - 2017

 

see attached

PCA NCA Guidelines Link

 

 see attached

National supply shortage of Diamorphine 5mg and 10mg Injections

The trust has received notification from the Department of Health & Social Care regarding a national supply shortage of Diamorphine 5mg and 10mg Injections. This shortage is anticipated to last until summer 2020. Please see the memo attached for further information for this drug shortage.

Intranasal diamorphine - Formulary

See Paediatric acute sickle cell pain guideline

Guidelines for treating acute pain in paediatric in-patients

See attached

  Powder for solution for injection
Diamorphine hydrochloride (Non-proprietary) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

 

see attached

PCA NCA Guidelines Link

 

 see attached

Diamorphine

Injection Formulation is Hospital Use Only

Prescribing in Palliative Care


http://www.pallcare.info/ - seek advice from Macmillan Team or Palliative Care teams before using information from this website:

http://bartshealthintranet/About-Us/CAGs/Cancer/Palliative-care/Index.aspx
Palliative Care Team Contacts:

St Bartholomew's, Royal London, Mile End and London Chest

Phone: 020 3465 5600 (internal: 55600)Fax: 020 3465 5389 (internal: 55389)

Newham Phone: 020 7363 8105 Fax: 020 7363 9432

Whipps Cross – Margaret Centre Phone: 020 8535 6604 Fax: 020 8535 6952

National supply shortage of Diamorphine 5mg and 10mg Injections

The trust has received notification from the Department of Health & Social Care regarding a national supply shortage of Diamorphine 5mg and 10mg Injections. This shortage is anticipated to last until summer 2020. Please see the memo attached for further information for this drug shortage.

Guidelines for treating acute pain in paediatric in-patients

See attached

  diclofenac potassium Off Formulary
  dihydrocodeine tartrate On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

Guidelines for use of Dihydrocodeine for paediatric sickle cell pain management

see attached

Guidelines for treating acute pain in paediatric in-patients

see attached

  Modified-release tablet
DHC Continus (Ennogen Healthcare International Ltd) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

  dihydrocodeine with paracetamol On Formulary
Guidelines for treating acute pain in paediatric in-patients June 2015

Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome).
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

  fentanyl On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

Guidelines for treating acute pain in paediatric in-patients February 2018

Oxycodone PCA is also approved for acute pain use at RLH.
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

PCA NCA Policy Link

FENTANYL

Hospital Use Only

NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

See attached

Acute pain relief in sickle cell pain crisis (April 2021)

The committee have approved sublingual Fentanyl for acute pain relief in sickle cell pain crisis in paediatric patients of age 14 years and above.

  Solution for injection
Fentanyl (Non-proprietary) On Formulary
  Solution for infusion
Fentanyl (Non-proprietary) On Formulary
  Transdermal patch
Durogesic DTrans (Janssen-Cilag Ltd) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

  hydromorphone hydrochloride Off Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

  ibuprofen On Formulary
Guidelines for treating acute pain in paediatric in-patients February 2018

Oxycodone PCA is also approved for acute pain use at RLH.
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

Bart's Health Clinical Practice Policy on Intravenous PCA/NCA for Paediatric Patients in Acute Pain

see attached

PAEDIATRIC ACUTE SICKLE CELL PAIN PATHWAY

see attached

The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

  levobupivacaine On Formulary
  Solution for injection
Chirocaine (AbbVie Ltd) On Formulary
  levomepromazine Hospital Only
  mefenamic acid On Formulary
  Oral suspension
Mefenamic acid (Non-proprietary) On Formulary
  methadone hydrochloride Off Formulary
  morphine On Formulary
PCA NCA Guidelines Link

see attached

Guidelines for treating acute pain in paediatric in-patients February 2018

Oxycodone PCA is also approved for acute pain use at RLH.
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

Bart's Health Clinical Practice Policy on Intravenous PCA/NCA for Paediatric Patients in Acute Pain

Injections

Hospital use only

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached 

  Modified-release tablet
MST Continus (Napp Pharmaceuticals Ltd) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

Guidelines for treating acute pain in paediatric in-patients June 2015

Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome).
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

see attached

PAEDIATRIC ACUTE SICKLE CELL PAIN PATHWAY

see attached

  Modified-release capsule
MXL (Napp Pharmaceuticals Ltd) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

Guidelines for treating acute pain in paediatric in-patients June 2015

Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome).
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

see attached

PAEDIATRIC ACUTE SICKLE CELL PAIN PATHWAY

see attached

  Oral solution
Morphine (Non-proprietary) On Formulary
Lloyds Pharmacy Outpatient Prescription Order & Proforma for Morphine Sulphate Oral Solution 10mg/5ml

see attached

Bart's Health Clinical Practice Policy on Intravenous PCA/NCA for Paediatric Patients in Acute Pain

see attached

The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

Guidelines for treating acute pain in paediatric in-patients June 2015

Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome).
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

see attached

PAEDIATRIC ACUTE SICKLE CELL PAIN PATHWAY

see attached

Oramorph (Glenwood GmbH) On Formulary
Lloyds Pharmacy Outpatient Prescription Order & Proforma for Morphine Sulphate Oral Solution 10mg/5ml

see attached

Bart's Health Clinical Practice Policy on Intravenous PCA/NCA for Paediatric Patients in Acute Pain

see attached

The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

Guidelines for treating acute pain in paediatric in-patients June 2015

Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome).
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

see attached

PAEDIATRIC ACUTE SICKLE CELL PAIN PATHWAY

see attached

  Solution for injection
Morphine (Non-proprietary) On Formulary
PCA NCA Policy Link

see attached

Sickle-Cell-Disease Management in Children

see attached

The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

Guidelines for treating acute pain in paediatric in-patients June 2015

Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome).
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

PAEDIATRIC ACUTE SICKLE CELL PAIN PATHWAY

see attached

Note:

Hospital use only

NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

see attached

  nitrous oxide On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

NITROUS OXIDE

Hospital Use Only

  oxycodone hydrochloride On Formulary
PCA NCA Policy Link

see attached

Guidelines for treating acute pain in paediatric in-patients February 2018

Oxycodone PCA is also approved for acute pain use at RLH.
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Modified-release tablet
OxyContin (Napp Pharmaceuticals Ltd) On Formulary
Guidelines for treating acute pain in paediatric in-patients June 2015

Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome).
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

  Oral solution
Oxycodone hydrochloride (Non-proprietary) On Formulary
PCA NCA Policy Link

see attached

Guidelines for treating acute pain in paediatric in-patients February 2018

Oxycodone PCA is also approved for acute pain use at RLH.
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

OxyNorm (Napp Pharmaceuticals Ltd) On Formulary
PCA NCA Policy Link

see attached

Guidelines for treating acute pain in paediatric in-patients February 2018

Oxycodone PCA is also approved for acute pain use at RLH.
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Solution for injection
Oxycodone hydrochloride (Non-proprietary) On Formulary
Guidelines for treating acute pain in paediatric in-patients February 2018

Oxycodone PCA is also approved for acute pain use at RLH.
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

OxyNorm (Napp Pharmaceuticals Ltd) On Formulary
PCA NCA Policy Link

see attached

Guidelines for treating acute pain in paediatric in-patients February 2018

Oxycodone PCA is also approved for acute pain use at RLH.
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  paracetamol On Formulary
Guidelines for treating acute pain in paediatric in-patients June 2018

Oxycodone PCA is also approved for acute pain use at RLH.
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

Bart's Health Clinical Practice Policy on Intravenous PCA/NCA for Paediatric Patients in Acute Pain

PARACETAMOL

Infusion 1g/100ml is hospital use only

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached 

NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH

see attached

Paracetamol for Patent Ductus Arteriosus (PDA) in neonates

Approved for use in April 2022 DTC.

  ropivacaine hydrochloride Off Formulary
Ropivacaine

Hospital Use Only

  tramadol hydrochloride On Formulary
Guidelines for treating acute pain in paediatric in-patients February 2018

Oxycodone PCA is also approved for acute pain use at RLH.
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.
Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone
Duration: approximately 2 weeks
Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

Tramadol Hydrochloride

Injection Formulation is Hospital Use Only

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Oral drops
Tramadol hydrochloride (Non-proprietary) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

Guidelines for treating acute pain in paediatric in-patients June 2015

Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome).
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.


Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone


Duration: approximately 2 weeks


Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

  Solution for injection
Tramadol hydrochloride (Non-proprietary) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

Guidelines for treating acute pain in paediatric in-patients June 2015

Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome).
It is reserved for use after morphine, fentanyl or ketamine combinations have been tried.


Patient Criteria:
1st line – morphine+/- ketamine
2nd line – fentanyl +/- ketamine
3rd line - oxycodone


Duration: approximately 2 weeks


Administration details
Oxycodone 1mg/kg up to 50mg made up to 50mL sodium chloride 0.9%

Tramadol Hydrochloride

Injection Formulation is Hospital Use Only

  tramadol with paracetamol Off Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

Nervous system / Headache
  clonidine hydrochloride Off Formulary
  Oral solution
Clonidine hydrochloride (Non-proprietary) Off Formulary
  Solution for injection
Catapres (Glenwood GmbH) Off Formulary
  pizotifen On Formulary
  sumatriptan On Formulary
  verapamil hydrochloride Off Formulary
Nervous system / Migraine
  amitriptyline hydrochloride Off Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

Barts Health Guidelines for Treating Acute Pain in Paediatric Patients

See attached

  Oral solution
Amitriptyline hydrochloride (Non-proprietary) On Formulary
  atenolol On Formulary
  botulinum toxin type A Off Formulary
  Powder for solution for injection
Bocouture (Merz Pharma UK Ltd) Off Formulary
Botox (AbbVie Ltd) Off Formulary
Dysport (Ipsen Ltd) Off Formulary
  clonidine hydrochloride Off Formulary
  Oral solution
Clonidine hydrochloride (Non-proprietary) Off Formulary
  Solution for injection
Catapres (Glenwood GmbH) Off Formulary
  cyclizine Off Formulary
Perioperative Prevention of Post Operative Nausea and Vomiting in Paediatric Patients

See attached

  diclofenac potassium Off Formulary
  paracetamol with buclizine hydrochloride and codeine phosphate On Formulary
  pizotifen On Formulary
  sodium valproate Off Formulary
  sumatriptan On Formulary
  Solution for injection
Sumatriptan (Non-proprietary) On Formulary
  timolol maleate Off Formulary
  topiramate On Formulary
Management of Infantile Spasms and West Syndrome

see attached

Antiepileptic Adjustment Chart

see attached

  valproic acid On Formulary
  zolmitriptan Off Formulary
Nervous system / Neuropathic pain
  amitriptyline hydrochloride On Formulary
  Oral solution
Amitriptyline hydrochloride (Non-proprietary) On Formulary
  carbamazepine On Formulary
Antiepileptic Adjustment Chart

see attached

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Modified-release tablet
Tegretol Retard (Novartis Pharmaceuticals UK Ltd) On Formulary
  Oral suspension
Carbamazepine (Non-proprietary) On Formulary
Tegretol (Novartis Pharmaceuticals UK Ltd) On Formulary
  Suppository
Carbamazepine (Non-proprietary) On Formulary
  gabapentin On Formulary
  nortriptyline Off Formulary
  oxycodone hydrochloride Off Formulary
  phenytoin Off Formulary
Nervous system / Dementia
  risperidone Off Formulary
Nervous system / Nausea and labyrinth disorders
  aprepitant Hospital Only
GOSH Supportive care protocol 2018

GOSH Supportive care protocol 2018

  chlorpromazine hydrochloride On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH

see attached

  Oral solution
Chlorpromazine hydrochloride (Non-proprietary) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

  cinnarizine On Formulary
  cyclizine On Formulary
Perioperative Prevention of Post Operative Nausea and Vomiting in Paediatric Patients

See attached

Bart's Health Clinical Practice Policy on Intravenous PCA/NCA for Paediatric Patients in Acute Pain

see attached

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

GOSH supportive care protocol

see attached

  Solution for injection
Cyclizine (Non-proprietary) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

Paediatric Oncology Local Guidelines July 14

see attached

  domperidone On Formulary
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

CF Prescribing Pathway Final Version 5 Dec 2015 SCG

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Oral suspension
Domperidone (Non-proprietary) On Formulary
NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH

see attached

  droperidol Off Formulary
  Solution for injection
Droperidol (Non-proprietary) Off Formulary
  fosaprepitant Off Formulary
  Powder for solution for infusion
Ivemend (Merck Sharp & Dohme (UK) Ltd) Off Formulary
  granisetron Off Formulary
  haloperidol On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Oral solution
Haloperidol (Non-proprietary) On Formulary
  Solution for injection
Haloperidol (Non-proprietary) On Formulary
Haloperidol

Injection formulation is Hospital Use Only

  hyoscine hydrobromide On Formulary
Paediatric Oncology Local Guidelines July 14


NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

HYOSCINE HYDROBROMIDE

Injection for hospital use only

  Solution for injection
Hyoscine hydrobromide (Non-proprietary) On Formulary
Hyoscine

Hospital Use Only

NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

Neonatal Formulary Version 9 2016 Barts Health

  Transdermal patch
Scopoderm (Baxter Healthcare Ltd) On Formulary
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

see attached

Paediatric Oncology Local Guidelines July 14

see attached

  levomepromazine Hospital Only
LEVOMEPROMAZINE

Hospital use only

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Solution for injection
Levomepromazine (Non-proprietary) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

LEVOMEPROMAZINE

Hospital use only

Nozinan (Neuraxpharm UK Ltd) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

LEVOMEPROMAZINE

Hospital use only

  lorazepam Off Formulary
  metoclopramide hydrochloride On Formulary
Paediatric Oncology Local Guidelines July 14


NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Oral solution
Metoclopramide hydrochloride (Non-proprietary) On Formulary
Paediatric Oncology Local Guidelines July 14

see attached

NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH

see attached

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Solution for injection
Metoclopramide hydrochloride (Non-proprietary) On Formulary
Paediatric Oncology Local Guidelines July 14

see attached

NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH

see attached

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  nabilone Off Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  ondansetron On Formulary
Perioperative Prevention of Post Operative Nausea Vomiting in Paediatric Patients 2017

See attached

Bart's Health Clinical Practice Policy on Intravenous PCA/NCA for Paediatric Patients in Acute Pain

Paediatric Oncology Local Guidelines July 14


ONDANSETRON

Injection for hospital use only

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached 

  Orodispersible tablet
Ondansetron (Non-proprietary) On Formulary
Paediatric Oncology Local Guidelines July 14

see attached

The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

  Oral solution
Ondansetron (Non-proprietary) On Formulary
Paediatric Oncology Local Guidelines July 14

see attached

The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

  Solution for injection
Ondansetron (Non-proprietary) On Formulary
Paediatric Oncology Local Guidelines July 14

see attached

The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

  prochlorperazine On Formulary
Prochlorperazine

Injection Formulation is Hospital use only

PROCHLORPERAZINE

Hospital use only

  Buccal tablet
Prochlorperazine (Non-proprietary) On Formulary
  Solution for injection
Stemetil (Sanofi) On Formulary
Prochlorperazine

Injection Formulation is Hospital use only

  promethazine hydrochloride On Formulary
  Oral solution
Phenergan (Sanofi Consumer Healthcare) On Formulary
  promethazine teoclate On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  trifluoperazine On Formulary
  Oral solution
Trifluoperazine (Non-proprietary) On Formulary
Nervous system / Insomnia
  chloral hydrate On Formulary
The Association of Paediatric Palliative Medicine Formulary -2017

See attached

NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH

see attached

  Oral solution
Chloral hydrate (Non-proprietary) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

  diazepam Off Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  melatonin On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Modified-release tablet
Melatonin (Non-proprietary) On Formulary
Melatonin Shared Care Guideline

Melatonin Shared Care Guideline 2014

Difficult to Obtain Letter

Difficult to Obtain Letter

Circadin (Flynn Pharma Ltd) On Formulary
Melatonin Shared Care Guidelines 2014

The Association of Paediatric Palliative Medicine Formulary - 2015

Difficult to Obtain Letter

  promethazine hydrochloride On Formulary
  Oral solution
Phenergan (Sanofi Consumer Healthcare) On Formulary
  temazepam Off Formulary
Nervous system / Narcolepsy
  dexamfetamine sulfate Off Formulary
  Modified-release capsule
Dexamfetamine sulfate (Non-proprietary) Off Formulary
Dexedrine Spansules (Imported (United States)) Off Formulary
  Oral solution
Dexamfetamine sulfate (Non-proprietary) Off Formulary
  methylphenidate hydrochloride Off Formulary
Nervous system / Dystonias and other involuntary movements
  botulinum toxin type A Hospital Only
BOTULINUM TOXIN use in Paediatrics

Hospital use only

Treatment of idiopathic constipation

Anorectal dysfunction following operations for Hirschsprung’s disease and Anorectal anomolies

oesophageal atresias

Focal Spasticity in children

  Powder for solution for injection
Bocouture (Merz Pharma UK Ltd) Hospital Only
Botox (AbbVie Ltd) Hospital Only
Botox®

Injection Formulation is Hospital use only

Dysport (Ipsen Ltd) Hospital Only
Dysport®

Injection Formulation is Hospital use only

  chlorpromazine hydrochloride On Formulary
  Oral solution
Chlorpromazine hydrochloride (Non-proprietary) On Formulary
  clonidine hydrochloride On Formulary
Clonidine use in Paediatrics

Sedation in PICU

Weaning sedation after PICU

 

ADHD is hospital only

 

  Oral solution
Clonidine hydrochloride (Non-proprietary) On Formulary
  Solution for injection
Catapres (Glenwood GmbH) Hospital Only
  clozapine On Formulary
CLOZAPINE

Hospital use only

  diazepam On Formulary
Diazepam

Injection formulation is Hospital Only

Sickle-Cell-Disease Management in Children

see attached

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH

see attached

  haloperidol On Formulary
  Oral solution
Haloperidol (Non-proprietary) On Formulary
  pericyazine Off Formulary
  procyclidine hydrochloride On Formulary
  trihexyphenidyl hydrochloride On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Oral solution
Trihexyphenidyl hydrochloride (Non-proprietary) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

Nervous system / Parkinson's disease
  co-careldopa On Formulary
  procyclidine hydrochloride On Formulary
  trihexyphenidyl hydrochloride Off Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached